Cytek Biosciences Announces Preliminary Full Year 2023 Reven

FREMONT, Calif., Jan. 08, 2024 -- Cytek Biosciences, Inc. , a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the full year ended December 31,...

Related Keywords

San Francisco , California , United States , China , Fremont , Cytek Aurora , Stephanie Olsen , Cytek Biosciences , Wenbin Jiang , Paul Goodson , Twitter , Cytek Biosciences Inc , Securities Exchange , European Union , Nasdaq , Linkedin , Exchange Commission , Lages Associates , Healthcare Conference , Full Spectrum Profiling , Northern Lights , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Quarterly Report , Markets ,